 | • レポートコード：MRC2307A0204 • 出版社/出版日：Transparency Market Research / 2023年5月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥811,300 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,231,300 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,651,300 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査資料によると、世界の便中免疫化学的診断検査（FIT）市場規模は2023年の13億ドルから2031年には21億ドルへ上り、予想期間中、年平均5.7％拡大すると予測されています。本調査資料では、便中免疫化学的診断検査（FIT）の世界市場を調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、製品別（キット・試薬、分析装置、その他）分析、エンドユーザー別（病院・診断研究所、専門診療所、在宅医療、研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などについて明らかにしています。なお、本書に記載されている企業情報には、Quest Diagnostics Incorporated、Sentinel CH. SpA、FUJIFILM Corporation、Quidel Corporation、Danaher (Beckman Coulter, Inc.)、Eiken Chemical Co., Ltd、Freenome Holdings, Inc.、Immunostics, Inc.、BTNX, Inc.、Biohit Oyj.などが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要洞察 ・世界の便中免疫化学的診断検査（FIT）市場規模：製品別 - キット・試薬の市場規模 - 分析装置の市場規模 - その他便中免疫化学的診断検査（FIT）の市場規模 ・世界の便中免疫化学的診断検査（FIT）市場規模：エンドユーザー別 - 病院・診断研究所における市場規模 - 専門診療所における市場規模 - 在宅医療における市場規模 - 研究機関における市場規模 ・世界の便中免疫化学的診断検査（FIT）市場規模：地域別 - 北米の便中免疫化学的診断検査（FIT）市場規模 - ヨーロッパの便中免疫化学的診断検査（FIT）市場規模 - アジア太平洋の便中免疫化学的診断検査（FIT）市場規模 - 中南米の便中免疫化学的診断検査（FIT）市場規模 - 中東・アフリカの便中免疫化学的診断検査（FIT）市場規模 ・競争状況 |
Fecal Immunochemical Diagnostic Test (FIT) Market – Scope of Report
TMR’s report on the global Fecal Immunochemical Diagnostic Test (FIT) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Fecal Immunochemical Diagnostic Test (FIT) market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Fecal Immunochemical Diagnostic Test (FIT) market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Fecal Immunochemical Diagnostic Test (FIT) market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Fecal Immunochemical Diagnostic Test (FIT) market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Fecal Immunochemical Diagnostic Test (FIT) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Fecal Immunochemical Diagnostic Test (FIT) market.
The report delves into the competitive landscape of the global Fecal Immunochemical Diagnostic Test (FIT) market. Key players operating in the global Fecal Immunochemical Diagnostic Test (FIT) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Fecal Immunochemical Diagnostic Test (FIT) market profiled in this report.
Key Questions Answered in Global Fecal Immunochemical Diagnostic Test (FIT) Market Report
• What is the sales/revenue generated by Fecal Immunochemical Diagnostic Test (FIT) across all regions during the forecast period?
• What are the opportunities in the global Fecal Immunochemical Diagnostic Test (FIT) market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Fecal Immunochemical Diagnostic Test (FIT) Market – Research Objectives and Research Approach
The comprehensive report on the global Fecal Immunochemical Diagnostic Test (FIT) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Fecal Immunochemical Diagnostic Test (FIT) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Fecal Immunochemical Diagnostic Test (FIT) market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Fecal Immunochemical Diagnostic Test (FIT) Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Regulatory Scenario
5.3. Pricing Analysis
5.4. COVID-19 Pandemic Impact on Industry
6. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Kits & Reagents
6.3.2. Analyzers
6.3.3. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals & Diagnostic Laboratories
7.3.2. Specialty Clinics
7.3.3. Home Care Settings
7.3.4. Research Institutes
7.4. Market Attractiveness Analysis, by End-user
8. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017-2031
9.2.1. Kits & Reagents
9.2.2. Analyzers
9.2.3. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals & Diagnostic Laboratories
9.3.2. Specialty Clinics
9.3.3. Home Care Settings
9.3.4. Research Institutes
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Kits & Reagents
10.2.2. Analyzers
10.2.3. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals & Diagnostic Laboratories
10.3.2. Specialty Clinics
10.3.3. Home Care Settings
10.3.4. Research Institutes
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Kits & Reagents
11.2.2. Analyzers
11.2.3. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals & Diagnostic Laboratories
11.3.2. Specialty Clinics
11.3.3. Home Care Settings
11.3.4. Research Institutes
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Kits & Reagents
12.2.2. Analyzers
12.2.3. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals & Diagnostic Laboratories
12.3.2. Specialty Clinics
12.3.3. Home Care Settings
12.3.4. Research Institutes
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Kits & Reagents
13.2.2. Analyzers
13.2.3. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals & Diagnostic Laboratories
13.3.2. Specialty Clinics
13.3.3. Home Care Settings
13.3.4. Research Institutes
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2022
14.3. Company Profiles
14.3.1. Quest Diagnostics Incorporated
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Sentinel CH. SpA
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. FUJIFILM Corporation
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Quidel Corporation
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Danaher (Beckman Coulter, Inc.)
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Eiken Chemical Co., Ltd.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Freenome Holdings, Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Immunostics, Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. BTNX, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Biohit Oyj
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
Table 01: Global Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 06: North America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 09: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 12: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 15: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 18: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031